Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$758.35M	-51.10%	-17.00%	-33.14%	-18.50%	1.87	6.60	18.30%	-70.40%	-58.14%
MANE	VERADERMICS INC	$2.40B	N/A	-80.10%	-58.11%	-139.60%	-0.08	16.66	N/A	N/A	N/A
GDRX	GOODRX HOLDINGS INC	$702.28M	4.80%	2.30%	8.56%	12.30%	1.28	2.61	92.80%	3.80%	12.44%
EOLS	EVOLUS INC	$262.19M	N/A	-23.30%	-20.77%	-17.50%	-10.78	1.90	66.30%	-17.40%	-10.52%
SOLV	SOLVENTUM CORP	$11.03B	36.70%	10.80%	18.46%	21.50%	1.83	1.23	53.50%	18.70%	24.74%
DCTH	DELCATH SYSTEMS INC	$334.61M	2.60%	2.40%	3.11%	4.90%	0.11	10.92	86.20%	3.20%	4.12%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$249.88M	-185.10%	-65.90%	-52.54%	-87.70%	0.96	6.45	99.40%	-158.20%	-153.97%
BIO	BIO-RAD LABORATORIES INC	$7.56B	10.90%	7.60%	10.38%	10.90%	0.42	5.62	51.90%	29.40%	40.43%
LEGN	LEGEND BIOTECH CORP	$3.54B	-29.20%	-17.60%	-23.80%	-36.80%	0.73	1.96	60.30%	-28.80%	-25.39%
ALLO	ALLOGENE THERAPEUTICS INC	$604.57M	-57.10%	-41.60%	-49.51%	-51.20%	0.42	7.93	N/A	N/A	N/A
ERAS	ERASCA INC	$5.54B	-34.50%	-28.70%	-33.88%	-32.40%	0.22	10.04	N/A	N/A	N/A
CNC	CENTENE CORP	$17.27B	-27.70%	-8.00%	-15.10%	-21.70%	2.84	1.10	7.10%	-3.40%	-3.10%
HYPD	HYPERION DEFI INC	$37.02M	-134.80%	-95.80%	-89.18%	-100.30%	0.26	2.68	62.70%	-5,777.70%	-5,379.11%
IVVD	INVIVYD INC	$361.72M	-48.70%	-34.50%	-21.63%	-414.90%	0.15	7.24	93.00%	-98.20%	-98.25%
HYPR	HYPERFINE INC	$110.69M	-97.40%	-72.80%	-81.72%	-352.80%	0.35	4.34	49.80%	-262.30%	-262.29%
OGN	ORGANON & CO	$1.66B	25.50%	1.40%	8.87%	7.10%	16.11	1.82	53.30%	3.00%	14.95%
NRC	NATIONAL RESEARCH CORP	$390.33M	58.50%	8.50%	23.01%	21.80%	8.64	0.55	61.90%	8.40%	16.45%
HROW	HARROW INC	$1.31B	-10.00%	-1.40%	7.52%	10.60%	6.62	2.20	75.10%	-1.90%	8.38%
CTKB	CYTEK BIOSCIENCES INC	$582.33M	-18.00%	-13.80%	-7.90%	-10.10%	0.35	5.04	51.80%	-33.00%	-15.05%
CDXS	CODEXIS INC	$165.38M	-90.50%	-32.60%	-31.94%	-26.50%	1.93	3.82	86.70%	-62.50%	-55.57%
MRNA	MODERNA INC	$19.43B	-30.10%	-22.90%	-26.74%	-28.30%	0.43	3.29	55.30%	-145.20%	-142.39%
PRLD	PRELUDE THERAPEUTICS INC	$217.99M	-130.00%	-80.90%	-112.65%	-138.00%	1.06	1.99	100.00%	-819.60%	-819.59%
LMRI	LUMEXA IMAGING HOLDINGS INC	$898.63M	-12.60%	-2.70%	5.44%	4.80%	2.01	1.27	15.40%	-4.60%	8.44%
HCM	HUTCHMED (CHINA) LTD	$2.69B	45.70%	30.20%	36.41%	45.60%	0.41	4.96	38.70%	83.30%	95.42%
WRBY	WARBY PARKER INC	$2.48B	0.50%	0.20%	-0.93%	-1.00%	0.96	2.35	54.00%	0.20%	-0.61%
MDLN	MEDLINE INC	$58.17B	8.60%	3.10%	5.73%	8.00%	1.79	4.29	26.40%	4.10%	7.25%
NBTX	NANOBIOTIX SA	$1.50B	N/A	-35.50%	-85.10%	-27.90%	-1.80	1.09	100.00%	-73.50%	-26.77%
SRZN	SURROZEN INC	$320.13M	N/A	-236.00%	-272.56%	-2,341.20%	-1.53	9.22	100.00%	-6,960.80%	-6,960.77%
ASTH	ASTRANA HEALTH INC	$1.39B	2.90%	1.20%	5.48%	10.30%	2.13	1.40	10.70%	0.70%	2.76%
PRGO	PERRIGO CO PLC	$1.49B	-35.20%	-14.80%	-15.40%	-18.70%	1.91	2.76	35.10%	-33.50%	-27.24%
OABI	OMNIAB INC	$222.97M	-24.00%	-21.40%	-23.29%	-87.50%	0.13	4.02	98.40%	-347.00%	-355.16%
ACIU	AC IMMUNE SA	$280.81M	-101.80%	-38.80%	-117.96%	-526.40%	2.44	1.02	100.00%	-1,971.60%	-1,966.30%
NUTX	NUTEX HEALTH INC	$703.25M	26.20%	8.10%	20.70%	18.00%	1.50	3.41	50.80%	8.10%	17.99%
ABCL	ABCELLERA BIOLOGICS INC	$1.07B	-14.80%	-10.70%	-13.74%	-15.00%	0.40	11.32	100.00%	-194.90%	-236.39%
SLS	SELLAS LIFE SCIENCES GROUP INC	$741.68M	-63.10%	-54.50%	-37.66%	3,232.60%	0.11	10.72	N/A	N/A	N/A
ASRT	ASSERTIO HOLDINGS INC	$123.81M	-30.30%	-10.60%	-19.26%	-28.30%	1.84	1.70	70.20%	-25.60%	-22.63%
TGTX	TG THERAPEUTICS INC	$5.35B	101.10%	51.90%	14.75%	15.80%	0.64	4.10	83.70%	72.60%	21.76%
RDNT	RADNET INC	$4.25B	-1.90%	-0.50%	2.08%	2.10%	2.21	1.76	11.50%	-0.90%	3.24%
CORT	CORCEPT THERAPEUTICS INC	$4.52B	15.10%	11.90%	6.46%	7.60%	0.29	2.92	98.30%	12.90%	5.69%
LAB	STANDARD BIOTOOLS INC	$354.18M	-17.60%	-13.40%	-24.54%	-34.90%	0.34	4.19	49.90%	-87.80%	-132.13%
GALT	GALECTIN THERAPEUTICS INC	$175.76M	N/A	-215.40%	-204.37%	-41.70%	-1.14	2.42	N/A	N/A	N/A
WGS	GENEDX HOLDINGS CORP	$1.94B	-7.40%	-4.40%	-4.48%	-7.80%	0.70	2.46	69.70%	-4.90%	-4.35%
SEER	SEER INC	$95.92M	-26.00%	-23.10%	-26.18%	-25.90%	0.14	12.84	51.10%	-444.00%	-442.75%
PLX	PROTALIX BIOTHERAPEUTICS INC	$173.23M	-13.50%	-8.30%	-7.91%	-9.80%	0.71	2.51	48.80%	-12.50%	-8.37%
CERT	CERTARA INC	$860.95M	-0.10%	-0.10%	1.95%	8.80%	0.47	2.05	61.50%	-0.40%	6.53%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$15.23B	-54.80%	-50.50%	-70.39%	-83.50%	0.18	7.39	N/A	N/A	N/A
NVCR	NOVOCURE LTD	$1.20B	-39.10%	-11.70%	-26.47%	-15.90%	1.36	2.90	74.50%	-20.80%	-23.47%
PSNL	PERSONALIS INC	$688.48M	-39.10%	-29.30%	-27.52%	-40.30%	0.28	6.76	22.70%	-116.70%	-116.36%
CV	CAPSOVISION INC	$370.80M	N/A	-153.80%	-184.11%	-470.00%	0.37	3.77	52.90%	-186.80%	-186.59%
URGN	UROGEN PHARMA LTD	$916.20M	N/A	-72.90%	-89.63%	-71.90%	-2.90	4.01	88.70%	-139.80%	-125.76%
GKOS	GLAUKOS CORP	$6.55B	-25.40%	-19.50%	-23.78%	-32.70%	0.36	4.69	55.70%	-37.00%	-37.13%
OVID	OVID THERAPEUTICS INC	$290.12M	-24.00%	-18.60%	-12.21%	-22.80%	0.16	8.97	100.00%	-240.10%	-240.13%
BCYC	BICYCLE THERAPEUTICS PLC	$352.02M	-33.20%	-27.40%	-33.09%	-530.20%	0.18	11.98	100.00%	-301.70%	-301.16%
FHTX	FOGHORN THERAPEUTICS INC	$278.80M	N/A	-33.50%	-53.69%	-74.10%	-2.83	2.73	100.00%	-240.30%	-240.33%
CRBU	CARIBOU BIOSCIENCES INC	$187.48M	-91.50%	-68.50%	-99.15%	-76.20%	0.44	5.72	100.00%	-1,327.40%	-1,332.33%
RNA	ATRIUM THERAPEUTICS INC	N/A	N/A	-637.10%	148.42%	233.10%	-1.13	0.07	100.00%	-265.90%	-266.64%
CTXR	CITIUS PHARMACEUTICALS INC	$19.11M	-52.50%	-27.60%	-33.67%	-48.00%	0.59	0.99	80.00%	-909.90%	-872.34%
SCLX	SCILEX HOLDING CO	$56.44M	N/A	-282.80%	389.82%	198.70%	-2.54	0.05	68.60%	-931.20%	-802.32%
MMED	MINIMED GROUP INC	N/A	N/A	N/A	N/A	N/A	0.21	1.77	N/A	N/A	N/A
GYRE	GYRE THERAPEUTICS INC	$690.38M	5.50%	3.30%	6.48%	9.80%	0.23	5.60	95.40%	4.30%	8.22%
PRTA	PROTHENA CORP PUBLIC LTD CO	$530.79M	-73.00%	-62.00%	-70.23%	3,211.20%	0.17	7.72	100.00%	-2,520.60%	-2,073.82%
NNNN	ANBIO BIOTECHNOLOGY	$3.72B	11.20%	11.00%	9.34%	17.00%	0.01	211.10	89.70%	37.20%	37.20%
AIDX	20/20 BIOLABS INC	$19.11M	-503.10%	-96.80%	-213.99%	-309.00%	-216.21	0.60	29.60%	-182.80%	-175.18%
MRKR	MARKER THERAPEUTICS INC	$22.01M	-80.90%	-67.00%	-72.51%	3,673.90%	0.14	8.39	100.00%	-343.00%	-343.39%
AVTX	AVALO THERAPEUTICS INC	$404.72M	-77.90%	-61.80%	-75.44%	-143.00%	0.40	8.14	100.00%	-132,642.40%	-132,362.71%
EKSO	EKSO BIONICS HOLDINGS INC	$33.50M	-110.50%	-50.70%	-99.22%	-101.40%	1.23	1.63	53.50%	-91.40%	-88.96%
TWST	TWIST BIOSCIENCE CORP	$3.08B	-16.60%	-12.20%	-13.55%	-20.90%	0.40	3.78	51.60%	-19.60%	-19.30%
DMRA	DAMORA THERAPEUTICS INC	$1.51B	-307.40%	-279.50%	-87.24%	6,125.20%	0.08	12.98	N/A	N/A	N/A
ACH	ACCENDRA HEALTH INC	$201.03M	N/A	-28.40%	-65.98%	-40.20%	-6.32	0.58	46.70%	-39.80%	-35.94%
AKBA	AKEBIA THERAPEUTICS INC	$369.67M	-16.70%	-1.50%	9.58%	33.50%	10.55	1.55	83.30%	-2.30%	8.66%
CHE	CHEMED CORP	$5.24B	23.90%	16.10%	28.58%	62.10%	0.57	1.05	32.50%	10.50%	14.13%
AMLX	AMYLYX PHARMACEUTICALS INC	$1.65B	-57.50%	-52.20%	-46.68%	-124.10%	0.09	14.27	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$14.18B	N/A	-74.40%	-103.60%	-32.00%	-1.44	2.77	95.80%	-144.40%	-133.72%
INGN	INOGEN INC	$169.11M	-11.60%	-7.40%	-9.94%	-21.80%	0.55	3.12	44.20%	-6.50%	-6.71%
GMAB	GENMAB A	$17.67B	17.40%	11.70%	12.87%	45.20%	1.20	2.02	93.60%	25.90%	39.60%
MESO	MESOBLAST LTD	$1.91B	-18.20%	-13.10%	-10.17%	-72.20%	0.36	1.58	80.50%	-144.30%	-101.79%
OSCR	OSCAR HEALTH INC	$3.55B	-39.50%	-7.30%	-28.71%	105.20%	5.47	0.95	14.40%	-3.80%	-3.59%
VYGR	VOYAGER THERAPEUTICS INC	$236.01M	-51.40%	-39.40%	-52.97%	-48.50%	0.29	7.64	100.00%	-296.50%	-296.17%
ONMD	ONEMEDNET CORP	$48.54M	N/A	-145.00%	102.21%	60.30%	-1.73	0.43	-37.00%	-206.10%	-201.10%
TIL	INSTIL BIO INC	$54.46M	-55.90%	-32.30%	-32.99%	-22.70%	0.79	39.53	N/A	N/A	N/A
ZYME	ZYMEWORKS INC	$1.90B	-26.00%	-20.60%	-26.22%	-28.30%	0.29	5.88	100.00%	-76.60%	-75.26%
NUVB	NUVATION BIO INC	$1.53B	-57.50%	-35.00%	-37.25%	-36.30%	0.95	6.95	85.20%	-325.30%	-303.56%
SIGA	SIGA TECHNOLOGIES INC	$375.42M	11.20%	10.00%	15.08%	73.70%	0.10	11.83	68.60%	24.60%	32.12%
BLTE	BELITE BIO INC	$6.68B	-16.90%	-16.60%	-10.07%	-29.10%	0.01	50.02	N/A	N/A	N/A
ECOR	ELECTROCORE INC	$54.97M	-2,072.10%	-79.00%	-182.72%	-150.50%	-11.92	1.38	86.80%	-43.60%	-41.75%
HCAT	HEALTH CATALYST INC	$86.10M	-54.70%	-27.40%	-38.94%	-67.70%	1.05	1.89	48.70%	-57.20%	-51.70%
POAS	PHAOS TECHNOLOGY (CAYMAN) HOLDINGS LTD	N/A	-1,073.10%	-144.30%	275.47%	9,727.00%	-1.99	0.40	22.10%	-3,063.10%	-3,058.07%
CYH	COMMUNITY HEALTH SYSTEMS INC	$410.33M	-31.60%	3.80%	12.98%	7.60%	-10.07	1.47	85.10%	4.10%	11.43%
RDY	DR REDDYS LABORATORIES LTD	$11.11B	18.40%	12.80%	21.76%	28.70%	0.47	1.92	58.50%	17.40%	24.24%
FTRE	FORTREA HOLDINGS INC	$883.58M	-152.20%	-34.60%	-49.47%	-67.30%	3.82	0.98	18.50%	-36.20%	-32.74%
SNSE	SENSEI BIOTHERAPEUTICS INC	$41.58M	-83.60%	-70.00%	-112.88%	-119.60%	0.23	5.06	N/A	N/A	N/A
UFPT	UFP TECHNOLOGIES INC	$1.48B	17.40%	10.60%	15.91%	23.60%	0.55	2.69	28.30%	11.30%	15.31%
SER	SERINA THERAPEUTICS INC	$26.11M	-1,487.60%	-221.90%	-559.36%	-5,505.00%	-188.87	1.71	100.00%	-14,950.80%	-14,577.69%
AGIO	AGIOS PHARMACEUTICALS INC	$2.06B	-31.10%	-28.90%	-34.06%	-31.40%	0.09	11.46	88.30%	-764.00%	-765.89%
HUM	HUMANA INC	$21.45B	6.60%	2.40%	6.35%	6.50%	1.77	2.00	14.50%	0.90%	1.60%
FATE	FATE THERAPEUTICS INC	$141.84M	-55.00%	-38.10%	-48.19%	-38.40%	0.54	5.79	100.00%	-2,051.10%	-2,051.08%
CRDF	CARDIFF ONCOLOGY INC	$108.02M	-82.00%	-64.10%	-100.79%	-109.80%	0.36	3.67	100.00%	-7,736.30%	-7,732.04%
NVAX	NOVAVAX INC	$1.25B	-546.20%	35.30%	64.85%	68.30%	-10.21	2.13	93.50%	39.20%	41.36%
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$169.00M	-88.20%	-74.30%	-130.19%	-237.60%	0.34	3.74	100.00%	-86,687.50%	-86,379.69%
IVA	INVENTIVA SA	$523.27M	N/A	-284.90%	-93.27%	-121.40%	-21.09	2.96	100.00%	-1,767.30%	-638.55%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	606	-0.01%	+3.43%	-0.16%	-29.10%	28.69x	4.77x	-38.36%	-14.24%	-8.58%	+63.52%	Strong Buy
Diagnostics & Research	55	+0.31%	+1.69%	-3.45%	+10.47%	20.41x	3.69x	-2.71%	+6.61%	+12.95%	+25.93%	Strong Buy
Drug Manufacturers - General	20	-1.34%	+2.11%	-6.55%	+20.55%	32.72x	7.01x	+10.22%	+12.41%	+21.10%	+19.20%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.19%	+0.83%	-6.28%	-27.18%	-196.18x	1.63x	+9.19%	+2.51%	+7.27%	+43.81%	Strong Buy
Healthcare Plans	10	+1.24%	+1.76%	-5.45%	-36.04%	22.78x	1.80x	+9.09%	+2.85%	+6.97%	+25.73%	Buy
Health Information Services	55	+0.55%	-0.27%	-8.49%	-80.30%	23.49x	2.80x	-7.72%	+2.33%	+4.64%	+61.04%	Buy
Medical Care Facilities	50	-0.22%	-1.38%	-10.26%	-42.38%	18.03x	5.29x	-68.62%	+7.35%	+19.11%	+25.02%	Buy
Medical Devices	137	-0.07%	-1.18%	-9.86%	-66.48%	23.94x	3.27x	+8.46%	+5.25%	+9.40%	+54.60%	Strong Buy
Medical Distribution	10	+1.45%	+2.26%	-10.46%	+25.96%	29.76x	317.88x	-99.39%	+3.30%	+23.34%	+14.03%	Strong Buy
Medical Instruments & Supplies	57	-0.61%	+0.07%	-7.92%	-10.20%	-490.95x	3.36x	+9.37%	+7.41%	+4.05%	+32.85%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 17 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock lose -5.68% over the past year, overperforming other healthcare stocks by 30 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 67.22% from Bioventus's current stock price of $8.97.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 8 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 52.75% over the past year, overperforming other healthcare stocks by 88 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 20.19% from Amneal Pharmaceuticals's current stock price of $12.48.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #3 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 32, which is 5 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 13.52% over the past year, overperforming other healthcare stocks by 49 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $10.00, an upside of 56.74% from Aveanna Healthcare Holdings's current stock price of $6.38.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 205.13%, which is 200 percentage points higher than the healthcare sector average of 4.92%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 24.18%, which is 19 percentage points higher than the healthcare sector average of 4.92%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.23%, which is 6 percentage points higher than the healthcare sector average of 4.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 162.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.05% in the last day, and up 1.62% over the last week. Lipocine was the among the top losers in the healthcare sector, dropping -77.84% yesterday.

Lipocine shares are trading lower after the company's LPCN 1154 missed its Phase 3 primary endpoint in postpartum depression.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 70 points higher than the healthcare sector average of 16. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -29.31% in the past year. It has overperformed other stocks in the healthcare sector by 6 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 145.83% in the past year. It has overperformed other stocks in the healthcare sector by 181 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -14.72% in the past year. It has overperformed other stocks in the healthcare sector by 21 percentage points.

Are healthcare stocks a good buy now?

58.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.05% over the next year.

5.73% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.7% of healthcare stocks are rated B (Buy), 50.93% are rated C (Hold), 23.91% are rated D (Sell), and 6.72% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is -8.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.